Case Report
Published on 24 Jun 2021
Case Report: Durvalumab-Associated Encephalitis in Extensive-Stage Small Cell Lung Carcinoma
in Cancer Immunity and Immunotherapy
![Case Report: Durvalumab-Associated Encephalitis in Extensive-Stage Small Cell Lung Carcinoma](https://www.frontiersin.org/files/myhome article library/693279/693279_Thumb_400.jpg)
- 3,310 views
- 4 citations
Case Report
Published on 24 Jun 2021
in Cancer Immunity and Immunotherapy
Original Research
Published on 24 Jun 2021
in Cancer Immunity and Immunotherapy
Case Report
Published on 24 Jun 2021
in Cancer Immunity and Immunotherapy
Review
Published on 23 Jun 2021
in Cancer Immunity and Immunotherapy
Clinical Trial
Published on 21 Jun 2021
in Cancer Immunity and Immunotherapy
Review
Published on 21 Jun 2021
in Cancer Immunity and Immunotherapy
Review
Published on 21 Jun 2021
in Cancer Immunity and Immunotherapy
Case Report
Published on 17 Jun 2021
in Cancer Immunity and Immunotherapy
Review
Published on 15 Jun 2021
in Cancer Immunity and Immunotherapy
Original Research
Published on 14 Jun 2021
in Cancer Immunity and Immunotherapy
Original Research
Published on 14 Jun 2021
in Cancer Immunity and Immunotherapy
Mini Review
Published on 11 Jun 2021
in Cancer Immunity and Immunotherapy
Original Research
Published on 10 Jun 2021
in Cancer Immunity and Immunotherapy
Review
Published on 10 Jun 2021
in Cancer Immunity and Immunotherapy
Original Research
Published on 10 Jun 2021
in Cancer Immunity and Immunotherapy
Original Research
Published on 09 Jun 2021
in Cancer Immunity and Immunotherapy